题名

Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases

DOI

10.1016/j.jtcme.2021.09.006

作者

Suraphan Panyod；Wei-Kai Wu；Chieh-Chang Chen；Ming-Shiang Wu；Chi-Tang Ho；Lee-Yan Sheen

关键词

Gut microbiota ； Microbial metabolite ； Cardiovascular disease ； Food ； Herbs

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

13卷2期（2023 / 03 / 01）

页次

107 - 118

内容语文

英文
中文摘要

Dietary nutrients are associated with the development of cardiovascular disease (CVD) both through traditional pathways (inducing hyperlipidemia and chronic inflammation) and through the emergence of a metaorganism-pathogenesis pathway (through the gut microbiota, its metabolites, and host). Several molecules from food play an important role as CVD risk-factor precursors either themselves or through the metabolism of the gut microbiome. Animal-based dietary proteins are the primary source of CVD risk-factor precursors; however, some plants also possess these precursors, though at relatively low levels compared with animal-source food products. Various medications have been developed to treat CVD through the gut-microbiota-circulation axis, and they exhibit potent effects in CVD treatment. Nevertheless, such medicines are still being improved, and there are many research gaps that need to be addressed. Furthermore, some medications have unpleasant or adverse effects. Numerous foods and herbs impart beneficial effects upon health and disease. In the past decade, many studies have focused on treating and preventing CVD by modulating the gut microbiota and their metabolites. This review provides an overview of the available information, summarizes current research related to the gut-microbiota-heart axis, enumerates the foods and herbs that are CVD-risk precursors, and illustrates how metabolites become CVD risk factors through the metabolism of gut microbiota. Moreover, we present perspectives on the application of foods and herbs-including prebiotics, probiotics, synbiotics, post-biotics, and antibiotic-like substances-as CVD prevention agents to modulate gut microbiota by inhibiting gut-derived CVD risk factors. Taxonomy (classification by EVISE): Cardiovascular disease, gut microbiota, herbal medicine, preventive medicine, dietary therapy, nutrition supplements.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Panyod, S,Sheen, LY(2020).Beneficial effects of Chinese herbs in the treatment of fatty liver diseases.J Tradit Complement Med,10(3),260-267.
    連結：
  2. Adeva-Andany, MM,Calvo-Castro, I,Fernandez-Fernandez, C,Donapetry-Garcia, C,Pedre-Pineiro, AM(2017).Significance of l-carnitine for human health.IUBMB Life,69(8),578-594.
  3. Anand, SS,Hawkes, C,de Souza, RJ(2015).Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the world heart federation.J Am Coll Cardiol,66(14),1590-1614.
  4. Andreesen, JR(1994).Glycine metabolism in anaerobes.Antonie Leeuwenhoek,66(1-3),223-237.
  5. Ankri, S,Mirelman, D(1999).Antimicrobial properties of allicin from garlic.Microb Infect,1(2),125-129.
  6. Araujo, A,Araujo, WMC,Marquez, UML,Akutsu, R,Nakano, EY(2017).Table of phenylalanine content of foods: comparative analysis of data compiled in food composition Tables.JIMD Rep.,34,87-96.
  7. Azcarate-Peril, MA(ed.),Arnold, RR(ed.),Bruno-Barcena, JM(ed.)(2019).How Fermented Foods Feed a Healthy Gut Microbiota: A Nutrition Continuum.Cham:Springer International Publishing.
  8. Bach Knudsen, KE,Laerke, HN,Hedemann, MS(2018).Impact of diet-modulated butyrate production on intestinal barrier function and inflammation.Nutrients,10(10)
  9. Banerjee, SK,Maulik, SK(2002).Effect of garlic on cardiovascular disorders: a review.Nutr J,1,4.
  10. Barabasi, AL,Menichetti, G,Loscalzo, J(2020).The unmapped chemical complexity of our diet (vol 1, pg 33, 2019).Nat Food,1(2),140-140.
  11. Bartolomaeus, H,Balogh, A,Yakoub, M(2019).Short-chain fatty acid propionate protects from hypertensive cardiovascular damage.Circulation,139(11),1407-1421.
  12. Beale, AL,O'Donnell, JA,Nakai, ME(2021).The gut microbiome of heart failure with preserved ejection fraction.J Am Heart Assoc.,10(13),e020654.
  13. Bosch, TCG,McFall-Ngai, MJ(2011).Metaorganisms as the new frontier.Zoology,114(4),185-190.
  14. Brown, JM,Hazen, SL(2015).The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.Annu Rev Med,66,343-359.
  15. Cardona, F,Andres-Lacueva, C,Tulipani, S,Tinahones, FJ,Queipo-Ortuno, MI(2013).Benefits of polyphenols on gut microbiota and implications in human health.J Nutr Biochem,24(8),1415-1422.
  16. Carmody, RN,Bisanz, JE,Bowen, BP(2019).Cooking shapes the structure and function of the gut microbiome.Nat Microbiol,4(12),2052-2063.
  17. Cerletti, C,Esposito, S,Iacoviello, L(2021).Edible mushrooms and beta-glucans: impact on human health.Nutrients,13(7)
  18. Chambers, ES,Preston, T,Frost, G,Morrison, DJ(2018).Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health.Curr Nutr Rep,7(4),198-206.
  19. Chan, YK,El-Nezami, H,Chen, Y,Kinnunen, K,Kirjavainen, PV(2016).Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE(-/-) mice.Amb Express,6
  20. Charach, G,Grosskopf, I,Rabinovich, A,Shochat, M,Weintraub, M,Rabinovich, P(2011).The association of bile acid excretion and atherosclerotic coronary artery disease.Therap Adv Gastroenterol,4(2),95-101.
  21. Chen, ML,Yi, L,Zhang, Y(2016).Resveratrol attenuates trimethylamine-N-oxide (TMAO)-Induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota.mBio,7(2),e02210-e02215.
  22. Chen, PY,Li, SM,Koh, YC(2019).Oolong tea extract and citrus peel polymethoxyflavones reduce transformation of L-carnitine to trimethylamine-Noxide and decrease vascular inflammation in L-carnitine feeding mice.J Agric Food Chem,67(28),7869-7879.
  23. Cheung, W,Keski-Rahkonen, P,Assi, N(2017).A metabolomic study of biomarkers of meat and fish intake.Am J Clin Nutr,105(3),600-608.
  24. Clarke, G,Stilling, RM,Kennedy, PJ,Stanton, C,Cryan, JF,Dinan, TG(2014).Minireview: gut microbiota: the neglected endocrine organ.Mol Endocrinol,28(8),1221-1238.
  25. Craciun, S,Balskus, EP(2012).Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme.Proc Natl Acad Sci U S A.,109(52),21307-21312.
  26. Craig, SA(2004).Betaine in human nutrition.Am J Clin Nutr,80(3),539-549.
  27. David, LA,Maurice, CF,Carmody, RN(2014).Diet rapidly and reproducibly alters the human gut microbiome.Nature,505(7484),559-563.
  28. Dos Santos, JP,Iobbi-Nivol, C,Couillault, C,Giordano, G,Mejean, V(1998).Molecular analysis of the trimethylamine N-oxide (TMAO) reductase respiratory system from a Shewanella species.J Mol Biol,284(2),421-433.
  29. Ercolini, D,Fogliano, V(2018).Food design to feed the human gut microbiota.J Agric Food Chem,66(15),3754-3758.
  30. Feng, W,Ao, H,Peng, C(2018).Gut microbiota, short-chain fatty acids, and herbal medicines.Front Pharmacol,9,1354.
  31. Feng, W,Ao, H,Peng, C,Yan, D(2019).Gut microbiota, a new frontier to understand traditional Chinese medicines.Pharmacol Res,142,176-191.
  32. Filipcev, B,Kojic, J,Krulj, J,Bodroza-Solarov, M,Ilic, N(2018).Betaine in cereal grains and grain-based products.Foods,7(4)
  33. Gentile, CL,Weir, TL(2018).The gut microbiota at the intersection of diet and human health.Science,362(6416),776-780.
  34. Górska-Warsewicz, H,Laskowski, W,Kulykovets, O,Kudlińska-Chylak, A,Czeczotko, M,Rejman, K(2018).Food products as sources of protein and amino acids-the case of Poland.Nutrients,10(12),1977.
  35. Gram, L,Dalgaard, P(2002).Fish spoilage bacteria-problems and solutions.Curr Opin Biotechnol,13(3),262-266.
  36. Hadi, A,Pourmasoumi, M,Kazemi, M,Najafgholizadeh, A,Marx, W(2021).Efficacy of synbiotic interventions on blood pressure: a systematic review and metaanalysis of clinical trials.Crit Rev Food Sci Nutr,1-11.
  37. Halliwell, B,Cheah, IK,Tang, RMY(2018).Ergothioneine - a diet-derived antioxidant with therapeutic potential.FEBS Lett,592(20),3357-3366.
  38. Harris, JC,Cottrell, SL,Plummer, S,Lloyd, D(2001).Antimicrobial properties of Allium sativum (garlic).Appl Microbiol Biotechnol,57(3),282-286.
  39. Heianza, Y,Ma, W,Manson, JE,Rexrode, KM,Qi, L(2017).Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies.J Am Heart Assoc.,6(7)
  40. Hoving, LR,Katiraei, S,Pronk, A(2018).The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden. CETP mice.Sci Rep-Uk,8
  41. Ishibashi, N,Yamazaki, S(2001).Probiotics and safety.Am J Clin Nutr,73(2 Suppl),465S-470S.
  42. Jamar, G,Ribeiro, DA,Pisani, LP(2021).High-fat or high-sugar diets as trigger inflammation in the microbiota-gut-brain axis.Crit Rev Food Sci.,61(5),836-854.
  43. Janeiro, MH,Ramirez, MJ,Milagro, FI,Martinez, JA,Solas, M(2018).Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target.Nutrients,10(10)
  44. Jaworska, K,Hering, D,Mosieniak, G(2019).TMA, A forgotten uremic toxin, but not TMAO, is involved in cardiovascular pathology.Toxins,11(9)
  45. Ji, Y,Yin, Y,Li, Z,Zhang, W(2019).Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD).Nutrients,11(8)
  46. Jiao, XY,Wang, YH,Lin, Y(2019).Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6 J mice by modulating the gut microbiota.Journal of Nutritional Biochemistry,64,88-100.
  47. Jie, Z,Xia, H,Zhong, SL(2017).The gut microbiome in atherosclerotic cardiovascular disease.Nat Commun,8(1),845.
  48. Jones, HJ,Krober, E,Stephenson, J(2019).A new family of uncultivated bacteria involved in methanogenesis from the ubiquitous osmolyte glycine betaine in coastal saltmarsh sediments.Microbiome,7(1),120.
  49. Kalaras, MD,Richie, JP,Calcagnotto, A,Beelman, RB(2017).Mushrooms: a rich source of the antioxidants ergothioneine and glutathione.Food Chem,233,429-433.
  50. Kao, TW,Huang, CC(2021).Recent progress in metabolic syndrome research and therapeutics.Int J Mol Sci.,22(13)
  51. Kasahara, K,Krautkramer, KA,Org, E(2018).Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model.Nat Microbiol,3(12),1461-1471.
  52. Kaye, DM,Shihata, WA,Jama, HA(2020).Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease.Circulation,141(17),1393-1403.
  53. Kazaks, A,Makrecka-Kuka, M,Kuka, J(2014).Expression and purification of active, stabilized trimethyllysine hydroxylase.Protein Expr Purif,104,1-6.
  54. Kelly, JR,Kennedy, PJ,Cryan, JF,Dinan, TG,Clarke, G,Hyland, NP(2015).Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders.Front Cell Neurosci,9,392.
  55. Kim, MH,Yun, KE,Kim, J(2020).Gut microbiota and metabolic health among overweight and obese individuals.Sci Rep-Uk,10(1)
  56. Koeth, RA,Lam-Galvez, BR,Kirsop, J(2019).l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.J Clin Invest,129(1),373-387.
  57. Koeth, RA,Levison, BS,Culley, MK(2014).Gamma-butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.Cell Metabol,20(5),799-812.
  58. Koeth, RA,Wang, ZE,Levison, BS(2013).Intestinal microbiota metabolism of Lcarnitine, a nutrient in red meat, promotes atherosclerosis.Nat Med,19(5),576-585.
  59. Korakas, E,Dimitriadis, G,Raptis, A,Lambadiari, V(2018).Dietary composition and cardiovascular risk: a mediator or a bystander?.Nutrients,10(12)
  60. Kvakova, M,Bertkova, I,Stofilova, J,Savidge, TC(2021).Co-encapsulated synbiotics and immobilized probiotics in human health and gut microbiota modulation.Foods,10(6)
  61. Lee-Yan, S,Suraphan, P,Wei-Kai, W(2021).,未出版
  62. Li, H,He, J,Jia, W(2016).The influence of gut microbiota on drug metabolism and toxicity.Expet Opin Drug Metabol Toxicol,12(1),31-40.
  63. Li, J,Lin, SQ,Vanhoutte, PM,Woo, CW,Xu, AM(2016).Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in apoe(-/-) mice.Circulation,133(24),2434.
  64. Li, Q,Gao, B,Siqin, B(2021).Gut microbiota: a novel regulator of cardiovascular disease and Key factor in the therapeutic effects of Flavonoids.Front Pharmacol,12,651926.
  65. Li, X,Su, C,Jiang, Z(2021).Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.NPJ Biofilms Microbiomes,7(1),36.
  66. Li, XMS,Wang, ZN,Cajka, T(2018).Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.Jci Insight,3(6)
  67. Lin, L,Zhang, J(2017).Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.BMC Immunol,18(1),2.
  68. Liperoti, R,Vetrano, DL,Bernabei, R,Onder, G(2017).Herbal medications in cardiovascular medicine.J Am Coll Cardiol,69(9),1188-1199.
  69. Liu, YC,Li, XY,Shen, L.(2020).Modulation effect of tea consumption on gut microbiota.Appl Microbiol Biotechnol,104(3),981-987.
  70. Maas, MN,Hintzen, JCJ,Porzberg, MRB,Mecinovic, J(2020).Trimethyllysine: from carnitine biosynthesis to epigenetics.Int J Mol Sci.,21(24)
  71. Makki, K,Deehan, EC,Walter, J,Backhed, F(2018).The impact of dietary fiber on gut microbiota in host health and disease.Cell Host Microbe,23(6),705-715.
  72. Marques, FZ,Nelson, E,Chu, PY(2017).High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice.Circulation,135(10),964.
  73. Marzullo, P,Di Renzo, L,Pugliese, G(2020).From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.Int J Obes Suppl,10(1),35-49.
  74. Matziouridou, C,Marungruang, N,Nguyen, TD,Nyman, M,Fak, F(2016).Lingonberries reduce atherosclerosis in Apoe(-/-) mice in association with altered gut microbiota composition and improved lipid profile.Mol Nutr Food Res,60(5),1150-1160.
  75. McRae, MP(2017).Dietary fiber is beneficial for the prevention of cardiovascular disease: an umbrella review of meta-analyses.J Chiropr Med,16(4),289-299.
  76. Moludi, J,Maleki, V,Jafari-Vayghyan, H,Vaghef-Mehrabany, E,Alizadeh, M(2020).Metabolic endotoxemia and cardiovascular disease: a systematic review about potential roles of prebiotics and probiotics.Clin Exp Pharmacol Physiol,47(6),927-939.
  77. Morales, D,Shetty, SA,Lopez-Plaza, B(2021).Modulation of human intestinal microbiota in a clinical trial by consumption of a beta-d-glucan-enriched extract obtained from Lentinula edodes.Eur J Nutr.,60(6),3249-3265.
  78. Muramatsu, H,Matsuo, H,Okada, N(2013).Characterization of ergothionase from Burkholderia sp. HME13 and its application to enzymatic quantification of ergothioneine.Appl Microbiol Biotechnol,97(12),5389-5400.
  79. Natarajan, N,Hori, D,Flavahan, S(2016).Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.Physiol Genom,48(11),826-834.
  80. Nemet, I,Saha, PP,Gupta, N(2020).A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors.Cell,180(5),862-877e822.
  81. Noble, N,Paul, C,Turon, H,Oldmeadow, C(2015).Which modifiable health risk behaviours are related? A systematic review of the clustering of Smoking, Nutrition, Alcohol and Physical activity ('SNAP') health risk factors.Prev Med,81,16-41.
  82. Ohira, H,Tsutsui, W,Fujioka, Y(2017).Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis?.J Atherosclerosis Thromb,24(7),660-672.
  83. Olas, B(2020).Probiotics, prebiotics and synbiotics-A promising strategy in prevention and treatment of cardiovascular diseases?.Int J Mol Sci,21(24)
  84. Panyod, S,Wu, WK,Ho, CT(2016).Diet supplementation with allicin protects against alcoholic fatty liver disease in mice by improving anti-inflammation and antioxidative functions.J Agric Food Chem,64(38),7104-7113.
  85. Panyod, S,Wu, WK,Lu, KH(2020).Allicin modifies the composition and function of the gut microbiota in alcoholic hepatic steatosis mice.J Agric Food Chem,68(10),3088-3098.
  86. Peluzio, MDG,Martinez, JA,Milagro, FI(2021).Postbiotics: metabolites and mechanisms involved in microbiota-host interactions.Trends Food Sci Technol,108,11-26.
  87. Plovier, H,Everard, A,Druart, C(2017).A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.Nat Med,23(1),107-113.
  88. Qiu, L,Tao, XY,Xiong, H,Yu, J,Wei, H(2018).Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.Food & Function,9(8),4299-4309.
  89. Rahman, K,Lowe, GM(2006).Garlic and cardiovascular disease: a critical review.J Nutr.,136(3 Suppl),736S-740S.
  90. Rath, S,Heidrich, B,Pieper, DH,Vital, M(2017).Uncovering the trimethylamine-producing bacteria of the human gut microbiota.Microbiome,5
  91. Riad, K,Travica, N,Sali, A(2018).The effect of Kyolic aged garlic extract on gut microbiota, inflammation, and cardiovascular markers in hypertensives: the GarGIC trial.Front Nutr,5
  92. Roberts, AB,Gu, X,Buffa, JA(2018).Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential.Nat Med,24(9),1407-1417.
  93. Romano, KA,Vivas, EI,Amador-Noguez, D,Rey, FE(2015).Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.mBio,6(2),e02481.
  94. Roth, GA,Johnson, C,Abajobir, A(2017).Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015.J Am Coll Cardiol,70(1),1-25.
  95. Ryan, PM,Stanton, C,Caplice, NM(2017).Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions.Diabetol Metab Syndrome,9,102.
  96. Schiattarella, GG,Sannino, A,Toscano, E(2017).Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.Eur Heart J,38(39),2948.
  97. Seline, KG,Johein, H(2007).The determination of L-carnitine in several food samples.Food Chem,105(2),793-804.
  98. Servillo, L,D'Onofrio, N,Giovane, A(2018).Ruminant meat and milk contain delta-valerobetaine, another precursor of trimethylamine N-oxide (TMAO) like gamma-butyrobetaine.Food Chem,260,193-199.
  99. Shao, B,Lu, M,Katz, SC(2007).A host lipase detoxifies bacterial lipopolysac-charides in the liver and spleen.J Biol Chem,282(18),13726-13735.
  100. Simo, C,Garcia-Canas, V(2020).Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.Food Funct,11(8),6745-6776.
  101. Simon, E,Calinoiu, LF,Mitrea, L,Vodnar, DC(2021).Probiotics, prebiotics, and synbiotics: implications and beneficial effects against irritable bowel syndrome.Nutrients,13(6)
  102. Smits, LP,Kootte, RS,Levin, E(2018).Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome.J Am Heart Assoc,7(7)
  103. Sobenin, IA,Pryanishnikov, VV,Kunnova, LM,Rabinovich, YA,Martirosyan, DM,Orekhov, AN(2010).The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease.Lipids Health Dis,9
  104. Soliman, GA(2019).Dietary fiber, atherosclerosis, and cardiovascular disease.Nutrients,11(5)
  105. Sorrenti, V,Ali, S,Mancin, L,Davinelli, S,Paoli, A,Scapagnini, G(2020).Cocoa polyphenols and gut microbiota interplay: bioavailability, prebiotic effect, and impact on human health.Nutrients,12(7)
  106. Staley, C,Weingarden, AR,Khoruts, A,Sadowsky, MJ(2017).Interaction of gut microbiota with bile acid metabolism and its influence on disease states.Appl Microbiol Biotechnol,101(1),47-64.
  107. Summers, G,Wibisono, RD,Hedderley, DI,Fletcher, GC(2017).Trimethylamine oxide content and spoilage potential of New Zealand commercial fish species.New Zeal J Mar Fresh,51(3),393-405.
  108. Sun, NX,Tong, LT,Liang, TT(2019).Effect of oat and tartary buckwheat - based food on cholesterol - lowering and gut microbiota in hypercholesterolemic hamsters.J Oleo Sci.,68(3),251-259.
  109. Tang, WH,Wang, Z,Levison, BS(2013).Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.N Engl J Med.,368(17),1575-1584.
  110. Tang, WHW,Kitai, T,Hazen, SL(2017).Gut microbiota in cardiovascular health and disease.Circ Res,120(7),1183-1196.
  111. Theuwissen, E,Mensink, RP(2008).Water-soluble dietary fibers and cardiovascular disease.Physiol Behav,94(2),285-292.
  112. Tilg, HA(2016).Gut feeling about thrombosis.N Engl J Med.,374(25),2494-2496.
  113. Ueland, PM(2011).Choline and betaine in health and disease.J Inherit Metab Dis,34(1),3-15.
  114. Ufnal, M,Zadlo, A,Ostaszewski, R(2015).TMAO: a small molecule of great expectations.Nutrition,31(11-12),1317-1323.
  115. Usami, M,Miyoshi, M,Yamashita, H(2015).Gut microbiota and host metabolism in liver cirrhosis.World J Gastroenterol,21(41),11597-11608.
  116. Vamanu, E,Gatea, F,Sarbu, I,Pelinescu, D(2019).An in vitro study of the influence of Curcuma longa extracts on the microbiota modulation process, in patients with hypertension.Pharmaceutics,11(4)
  117. Velmurugan, G,Dinakaran, V,Rajendhran, J,Swaminathan, K(2020).Blood microbiota and circulating microbial metabolites in diabetes and cardiovascular disease.Trends Endocrinol Metabol,31(11),835-847.
  118. Waksman SA. What is an antibiotic or an antibiotic substance. Mycologia. 1947;39(5):565-569.
  119. Wang, YA,Ames, NP,Tun, HM,Tosh, SM,Jones, PJ,Khafipour, E(2016).High molecular weight barley beta-glucan alters gut microbiota toward reduced cardiovascular disease risk.Front Microbiol,7
  120. Wang, ZN,Klipfell, E,Bennett, BJ(2011).Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.Nature,472(7341),57-U82.
  121. Wang, ZN,Roberts, AB,Buffa, JA(2015).Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis.Cell,163(7),1585-1595.
  122. Wang, ZN,Zhao, YZ(2018).Gut microbiota derived metabolites in cardiovascular health and disease.Protein Cell,9(5),416-431.
  123. Wiedeman, AM,Barr, SI,Green, TJ,Xu, Z,Innis, SM,Kitts, DD(2018).Dietary choline intake: current state of knowledge across the life cycle.Nutrients,10(10)
  124. Witkowski, M,Weeks, TL,Hazen, SL(2020).Gut microbiota and cardiovascular disease.Circ Res,127(4),553-570.
  125. Wu, WK,Chen, CC,Liu, PY(2019).Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice.Gut.,68(8),1439-1449.
  126. Wu, WK,Panyod, S,Ho, CT,Kuo, CH,Wu, MS,Sheen, LY(2015).Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota.J Funct Foods,15,408-417.
  127. Wu, WK,Panyod, S,Liu, PY(2020).Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery.Microbiome,8(1)
  128. Yoon, HS,Cho, CH,Yun, MS(2021).Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice.Nat Microbiol,6(5),563-573.
  129. Zeisel, SH,da Costa, KA(2009).Choline: an essential nutrient for public health.Nutr Rev,67(11),615-623.
  130. Zhao, D,Liu, J,Wang, M,Zhang, X,Zhou, M(2019).Epidemiology of cardiovascular disease in China: current features and implications.Nat Rev Cardiol,16(4),203-212.
  131. Zhu, W,Gregory, JC,Org, E(2016).Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk.Cell,165(1),111-124.
  132. Zhu, WF,Wang, ZN,Tang, WHW,Hazen, SL(2017).Gut microbe-generated trimethylamine N-oxide from dietary choline is prothrombotic in subjects.Circulation,135(17),1671-1673.
  133. Zhu, Y,Jameson, E,Crosatti, M(2014).Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota.Proc Natl Acad Sci U S A.,111(11),4268-4273.
  134. Zolkiewicz, J,Marzec, A,Ruszczynski, M,Feleszko, W(2020).Postbiotics-A step beyond pre- and probiotics.Nutrients,12(8)
print cancel